Form 8-K - Current report:
SEC Accession No. 0001493152-25-003707
Filing Date
2025-01-27
Accepted
2025-01-27 07:00:36
Documents
41
Period of Report
2025-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40996
2 ex99-1.htm EX-99.1 12882
3 ex99-2.htm EX-99.2 20696
4 ex99-1_001.jpg GRAPHIC 5214
5 ex99-2_001.jpg GRAPHIC 562302
6 ex99-2_002.jpg GRAPHIC 1743239
7 ex99-2_003.jpg GRAPHIC 1083763
8 ex99-2_004.jpg GRAPHIC 835064
9 ex99-2_005.jpg GRAPHIC 1215153
10 ex99-2_006.jpg GRAPHIC 965633
11 ex99-2_007.jpg GRAPHIC 794742
12 ex99-2_008.jpg GRAPHIC 752342
13 ex99-2_009.jpg GRAPHIC 806066
14 ex99-2_010.jpg GRAPHIC 625352
15 ex99-2_011.jpg GRAPHIC 758797
16 ex99-2_012.jpg GRAPHIC 912961
17 ex99-2_013.jpg GRAPHIC 552621
18 ex99-2_014.jpg GRAPHIC 819006
19 ex99-2_015.jpg GRAPHIC 712141
20 ex99-2_016.jpg GRAPHIC 1085392
21 ex99-2_017.jpg GRAPHIC 603436
22 ex99-2_018.jpg GRAPHIC 321919
23 ex99-2_019.jpg GRAPHIC 1099601
24 ex99-2_020.jpg GRAPHIC 1137298
25 ex99-2_021.jpg GRAPHIC 666634
26 ex99-2_022.jpg GRAPHIC 941109
27 ex99-2_023.jpg GRAPHIC 1380893
28 ex99-2_024.jpg GRAPHIC 690533
29 ex99-2_025.jpg GRAPHIC 743116
  Complete submission text file 0001493152-25-003707.txt   30250781

Data Files

Seq Description Document Type Size
30 XBRL SCHEMA FILE gtbp-20250127.xsd EX-101.SCH 3024
31 XBRL LABEL FILE gtbp-20250127_lab.xml EX-101.LAB 34240
32 XBRL PRESENTATION FILE gtbp-20250127_pre.xml EX-101.PRE 22365
43 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3681
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 25555727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)